ISSN: 1359-4184

Journal Home

Journal Guideline

Molecular Psychiatry Q1 Unclaimed

Nature Publishing Group United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Molecular Psychiatry is a journal indexed in SJR in Molecular Biology and Cellular and Molecular Neuroscience with an H index of 237. It has a price of 3690 €. It has an SJR impact factor of 3,541 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,541.

Molecular Psychiatry focuses its scope in these topics and keywords: genetic, adult, gene, association, neurogenesis, polymorphism, depressive, candidate, syndrome, brain, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Cellular and Molecular Neuroscience (Q1) Molecular Biology (Q1) Psychiatry and Mental Health (Q1)

Price

3690 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

3,541

SJR Impact factor

237

H Index

526

Total Docs (Last Year)

1076

Total Docs (3 years)

40961

Total Refs

10704

Total Cites (3 years)

969

Citable Docs (3 years)

9.29

Cites/Doc (2 years)

77.87

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Molecular Cell Q1
Annual Review of Plant Biology Q1
Cell Research Q1
Nature Structural & Molecular Biology Q1
Nature Protocols Q1

Compare this journals

Aims and Scope

Best articles by citations

A leadership crisis in American psychiatry

Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers

Inhibition of System A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action

Interleukin-1beta and interleukin-1 receptor antagonist do not affect glutamate release or calcium entry in rat striatal synaptosomes

The phenotypes of bipolar disorder: relevance for genetic investigations

Histochemical localization of Abeta peptide in APP 23 mouse brain

A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease

A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorder

Oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells express glutamine synthetase: developmental and cell type-specific regulation

Family factors and sampling approach differentially influence attention deficit/hyperactivity disorder subtypes

Correlation of length of VNTR alleles at the X-linked MAOA gene and phenotypic effect in Tourette syndrome and drug abuse

The BDNF val66met polymorphism is not associated with late onset Alzheimer's disease in three case-control samples

SHOW MORE ARTICLES

Baculoviruses expressing the human familial Alzheimer's disease presenilin 1 mutation lacking exon 9 increase levels of an amyloid beta-like protein in Sf9 cells

Schizophrenic women with the APOE e4 allele have a worse prognosis than those without it

Association between Novelty Seeking and the -521 C/T polymorphism in the promoter region of the DRD4 gene

Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia

Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia

Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype

Support for the MnlI polymorphism of SNAP25; a Korean ADHD case-control study

Co-localisation of IgG and complement C1q on the small intestinal epithelium in an autistic child

Excess of allele1 for a3 subunit GABA receptor gene (GABRA3) in bipolar patients: a multicentric association study

Evidence for the association of the S100beta gene with low cognitive performance and dementia in the elderly

Blockade of CRF1 or V1B receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression

A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression